Related Experiment Videos
Malignant mixed müllerian tumor of the fallopian tube
J A Carlson1, B L Ackerman, J E Wheeler
1Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia.
Cancer
|January 1, 1993
Abstract
Background:
Malignant mixed müllerian tumor (MMT) of tubal origin is rare and optimal therapy is unknown.
Methods:
Five new cases of MMT of the fallopian tube are presented, and the previous literature is reviewed.
Results:
Eight of 10 patients disease-free at 36 months had long-term cancer-free survival. Surgery alone was inadequate therapy even for those with apparent Stage I disease. Five of six treated postoperatively with radiation and chemotherapy have lived disease-free for at least 45 months.
Conclusions:
Combination radiation and chemotherapy may offer improved outcome.